Markets
News
Analysis
Tools
Learn
Stock
Score
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Start for free
News
All
Editors' Picks
Forex
Commodities
Stocks
Indices
Cryptocurrencies
Technical Analysis
Economic Indicator
Other
Important Only
Other
Regeneron Pharmaceuticals Inc Says Libtayo Shows 68% Reduction In Risk Of Disease Recurrence Or Death
May 31 (Reuters) - Regeneron Pharmaceuticals Inc REGN.O:REGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 68% REDUCTION IN RISK OF DISEASE RECURRENCE OR DEATHREGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 80% REDUCTION IN LOCOREGIONAL RECURRENCE RISKREGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 65% REDUC...
Reuters
Sat, May 31
Other
Novocure Says Ttfields Therapy Shows Significant Improvement In Overall Survival For Pancreatic Cancer
May 31 (Reuters) - Novocure Ltd NVCR.O:RESULTS FROM THE PHASE 3 PANOVA-3 TRIAL OF NOVOCURE’S TUMOR TREATING FIELDS (TTFIELDS) THERAPY FOR PANCREATIC CANCER TO BE PRESENTED AT 2025 ASCO ANNUAL MEETINGNOVOCURE LTD - TTFIELDS THERAPY SHOWS SIGNIFICANT IMPROVEMENT IN OVERALL SURVIVAL FOR PANCREATIC CANC...
Reuters
Sat, May 31
Other
Xilio Therapeutics Announces Updated Phase 2 Data For Vilastobart, A Tumor-Activated Anti-Ctla-4, In Combination With Atezolizumab In Patients With Metastatic Microsatellite Stable Colorectal Cancer
May 31 (Reuters) - Xilio Therapeutics Inc XLO.O:XILIO THERAPEUTICS ANNOUNCES UPDATED PHASE 2 DATA FOR VILASTOBART, A TUMOR-ACTIVATED ANTI-CTLA-4, IN COMBINATION WITH ATEZOLIZUMAB IN PATIENTS WITH METASTATIC MICROSATELLITE STABLE COLORECTAL CANCERXILIO THERAPEUTICS INC - 26% RESPONSE RATE IN METASTAT...
Reuters
Sat, May 31
Other
Merck Says Keytruda® Plus Trodelvy® Reduced Risk Of Disease Progression Or Death By 35% Versus Keytruda Plus Chemotherapy In First-Line Pd-L1+ Metastatic Triple-Negative Breast Cancer
May 31 (Reuters) - Merck MRK.N: KEYTRUDA® (PEMBROLIZUMAB) PLUS TRODELVY® (SACITUZUMAB GOVITECAN-HZIY) REDUCED RISK OF DISEASE PROGRESSION OR DEATH BY 35% VERSUS KEYTRUDA PLUS CHEMOTHERAPY IN FIRST-LINE PD-L1+ METASTATIC TRIPLE-NEGATIVE BREAST CANCER (TNBC)MERCK & CO INC - KEYTRUDA PLUS TRODELVY ...
Reuters
Sat, May 31
Stocks
This Is the Average Social Security Benefit for Early Claimers
Social Security benefits can be claimed between the ages of 62 and 70. However, every retiree has been given a full retirement age (FRA) based on their birth year. FRA is the age you get your standard benefit. Claiming anytime before FRA will shrink that standard check amount, leaving retired worker...
The Motley Fool
Sat, May 31
Stocks
3 Magnificent Dividend Stocks Down 15% to 64% to Buy and Hold for 20 Years
This is a great time to consider adding quality dividend stocks to your investment portfolio. Recent headwinds in the economy have weighed on sales of leading retail and consumer goods brands, and this has driven their stocks down and their yields higher.While the near term could be rocky, investors...
The Motley Fool
Sat, May 31
Other
Gilead's Trodelvy, with Keytruda, cuts breast cancer risk by 35% in trial
Trodelvy/Keytruda patients had 11.2 months progression-free survival vs 7.8 months for chemotherapy/Keytruda ASCO says Trodelvy/Keytruda likely to become standard of carePatients still being followed to see if combination extends survivalBy Deena Beasley May 31 (Reuters) - Gilead Sciences' GI...
Reuters
Sat, May 31
Commodities
EU Commission 'strongly' regrets announced increase in US steel tariffs
BRUSSELS, May 31 (Reuters) - The European Commission said on Saturday that it "strongly" regrets an announced increase in U.S. tariffs on steel imports. U.S. President Donald Trump said on Friday he planned to increase tariffs on imported steel and aluminum to 50% from 25%, putting more...
Reuters
Sat, May 31
Other
Israel says after IAEA report, the international community must stop Iran
JERUSALEM, May 31 (Reuters) - Israel said on Saturday that the latest report from the International Atomic Energy Agency showed that Iran's nuclear programme was not peaceful and that Tehran remained determined to complete its nuclear weapons programme."The international community must act n...
Reuters
Sat, May 31
Stocks
Does This Move Make Medtronic Stock a Buy?
Over the past few years, Medtronic (NYSE: MDT) has faced significant challenges, including a pandemic-induced slowdown, relatively slow revenue growth, and economic issues that impacted its financial results. Throughout it all, Medtronic's diabetes care business has consistently been one of its fast...
The Motley Fool
Sat, May 31
Cryptocurrencies
Sharplink to spend $1 billion for ETH treasury
Sharplink Gaming Inc. is one of the latest to employ Strategy’s playbook of accumulating crypto as reserve assets. However, instead of BTC, the company is looking to use it to acquire Ethereum (ETH).
Cryptopolitan
Sat, May 31
Cryptocurrencies
Fed’s Daly expresses ‘relief’ over April's PCE inflation, warns that the fight’s not over
Mary Daly, who runs the San Francisco branch of the Fed, said on Friday that while the latest inflation figure brings some “relief” to Americans, the central bank isn’t done yet. The comment came during her appearance on Maria Bartiromo’s Wall Street on Fox Business, where she was talking about the 2.1% rise in April’s […]
Cryptopolitan
Sat, May 31
Cryptocurrencies
XRP Set For Price Relief, But Only If Bulls Defend Key $2.13 Price Level – Details
Popular crypto analyst with X username CasiTrades has shared an interesting technical analysis on the XRP market that postulates a potential short-term price gain. Notably, XRP prices have dipped by over 7% in the past week amidst a general crypto price correction.However, CasiTrades predicts there ...
NewsBTC
Sat, May 31
Cryptocurrencies
No Room For Doubt: Analyst’s $900K Bitcoin Forecast Follows Familiar Script
Bitcoin’s price slipped to $105,235 today, dropping 1.5% over the past 24 hours and falling 4.2% in the last week. Some market watchers see this dip as a pause before a major move. According to their charts, Bitcoin could be gearing up for another steep gain. Related Reading: $400K Bitcoin? Analyst ...
NewsBTC
Sat, May 31
Stocks
47% of Berkshire Hathaway's $276 Billion Warren Buffett-Led Portfolio Is Invested in 3 Dividend Stocks
When Warren Buffett steps down as the CEO of Berkshire Hathaway at the end of this year, he will leave behind a legacy as perhaps the greatest investor of his time. As of the end of 2024, Berkshire Hathaway stock had gained an astounding 5,502,284% since Buffett took it over, and one way he turned i...
The Motley Fool
Sat, May 31
Stocks
What's Driving the Success of Palantir Stock?
Palantir's (NASDAQ: PLTR) stock price is up over 400% over a trailing-12-month period.Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »*Stock prices used were the afternoon prices of May 28, 2025. The video was pu...
The Motley Fool
Sat, May 31
Cryptocurrencies
This Cheap Altcoin at $0.03 is Ready for 10,000% Gains to Outshine Solana (SOL) in 2025
In a market flooded with hype and volatility, spotting the next big cryptocurrency early can be the key to life-changing returns. With Solana (SOL) still basking in its Layer-1 success, many investors are now shifting focus toward undervalued gems with higher upside. One such cheap altcoin, Mutuum Finance is gaining traction fast, with analysts projecting […]
Cryptopolitan
Sat, May 31
Cryptocurrencies
US court opposes a Coinbase user’s privacy appeal
The US government asked the Supreme Court to reject a Coinbase user's effort to block the IRS from accessing his crypto records.
Cryptopolitan
Sat, May 31
Stocks
The Smartest High-Yield Stocks to Buy With $100 Right Now
You can buy some smart high-yield investments with as little as $100 if you take your time and act selectively. Right now, United Parcel Service (NYSE: UPS), Brookfield Renewable Partners (NYSE: BEP), and Enterprise Products Partners (NYSE: EPD) all have 6% yields or higher, and share prices that ar...
The Motley Fool
Sat, May 31
Other
Rome's 'Hollywood on the Tiber' plans comeback despite Trump tariff threat
Cinecitta plans to boost production capacity by 60% by 2026Trump's proposed tariffs threaten global film industry setupItaly's tax credit attracts international film productionsBy Enrico Sciacovelli ROME, May 31 (Reuters) - Europe's largest film studio Cinecitta is aiming to re-launch...
Reuters
Sat, May 31
1
...
296
297
298
299
300
next page
KeyAI
Please log in to use KeyAI
Log in
Start for free